Do not use hydroxyethyl starch (HES) product in critically ill adult patients including patients with sepsis due to increased risk of mortality and renal replacement therapy.
Do not use HES product, in patients with severe liver disease.
Do not use HES products in patients with renal failure with oliguria or anuria not related to hypovolemia.
Do not use HES products in patients receiving dialysis treatment.